Colorectal Cancer: Genetics of Development and Metastasis

Overview

Journal J Gastroenterol

Specialty Gastroenterology

Date 2006 May 16

PMID 16699851

Citations 111

Authors

Tetsuji Takayama

Koji Miyanishi

Tsuyoshi Hayashi

Yasushi Sato

Yoshiro Niitsu

Affiliations

Soon will be listed here.

Abstract

It has been well documented that there are two major pathways in colorectal carcinogenesis. One is the chromosomal instability pathway (adenoma-carcinoma sequence), which is characterized by allelic losses on chromosome 5q (APC), 17p (p53), and 18q (DCC/SMAD4), and the other is a pathway that involves microsatellite instability. Recent progress in molecular biology, however, has shown that colorectal carcinogenesis is not necessarily clearly divided into these two pathways, but is in fact more complicated. Other routes, including the transforming growth factor-beta/SMAD pathway, the serrated pathway, and the epigenetic pathway, have been reported. Cross talk among these pathways has also been reported. In the invasion and metastasis steps of colorectal cancers, many more genes have now been identified as being involved in proteolysis, adhesion, angiogenesis, and cell growth. Recently accumulated evidence indicates that colorectal cancer is a genetically heterogeneous and complicated disease.

Citing Articles

The role of microalgal extracts and their combination with tamoxifen in the modulation of breast cancer immunotherapy (Review).

Al-Shajrawi O, Tarawneh I, Tengku Din T, Afolabi H Mol Clin Oncol. 2024; 22(1):6.

PMID: 39559458 PMC: 11570877. DOI: 10.3892/mco.2024.2801.

Unveiling the role of in Chinese colorectal cancer patients: a positive influence on tumor mutational burden.

Wan X, Zhang X, Xu M, Zheng Z, Zhou Y, Zhong Z Transl Cancer Res. 2024; 13(9):4752-4762.

PMID: 39430843 PMC: 11483435. DOI: 10.21037/tcr-24-600.

Bioengineered Anthocyanin-Enriched Tomatoes: A Novel Approach to Colorectal Cancer Prevention.

Suzauddula M, Kobayashi K, Park S, Sun X, Wang W Foods. 2024; 13(18).

PMID: 39335919 PMC: 11430996. DOI: 10.3390/foods13182991.

Whole exome sequencing in relapsed or refractory childhood cancer: case series.

Thangpong R, Nuwongsri P, Ittiwut C, Ittiwut R, Phokaew C, Techavichit P Asian Biomed (Res Rev News). 2024; 18(4):186-191.

PMID: 39309469 PMC: 11414774. DOI: 10.2478/abm-2024-0025.

NME1 and DCC variants are associated with susceptibility and tumor characteristics in Mexican patients with colorectal cancer.

Marquez-Gonzalez R, Saucedo-Sarinana A, Tovar-Jacome C, Barros-NuneZ P, Gallegos-Arreola M, Orozco-Gutierrez M J Egypt Natl Canc Inst. 2024; 36(1):10.

PMID: 38556604 DOI: 10.1186/s43046-024-00213-7.

References

Malkhosyan S, Rampino N, Yamamoto H, Perucho M . Frameshift mutator mutations. Nature. 1996; 382(6591):499-500. DOI: 10.1038/382499a0. View

Hamelin R, Laurent-Puig P, Olschwang S, Jego N, Asselain B, Remvikos Y . Association of p53 mutations with short survival in colorectal cancer. Gastroenterology. 1994; 106(1):42-8. DOI: 10.1016/s0016-5085(94)94217-x. View

Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N . The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol. 2005; 23(30):7518-28. DOI: 10.1200/JCO.2005.00.471. View

Ishikawa T, Ichikawa Y, Mitsuhashi M, Momiyama N, Chishima T, Tanaka K . Matrilysin is associated with progression of colorectal tumor. Cancer Lett. 1996; 107(1):5-10. DOI: 10.1016/0304-3835(96)04336-4. View

Downward J . Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003; 3(1):11-22. DOI: 10.1038/nrc969. View

Strater J, Hinz U, Walczak H, Mechtersheimer G, Koretz K, Herfarth C . Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter. Clin Cancer Res. 2002; 8(12):3734-40. View

Wagner H, Toth C, Steele Jr G, Thomas P . Metastatic potential of human colon cancer cell lines: relationship to cellular differentiation and carcinoembryonic antigen production. Clin Exp Metastasis. 1992; 10(1):25-31. DOI: 10.1007/BF00163573. View

Takebayashi Y, Aklyama S, Yamada K, Akiba S, Aikou T . Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer. 1996; 78(2):226-31. DOI: 10.1002/(SICI)1097-0142(19960715)78:2<226::AID-CNCR6>3.0.CO;2-J. View

Yoshitaka T, Matsubara N, Ikeda M, Tanino M, Hanafusa H, Tanaka N . Mutations of E2F-4 trinucleotide repeats in colorectal cancer with microsatellite instability. Biochem Biophys Res Commun. 1996; 227(2):553-7. DOI: 10.1006/bbrc.1996.1544. View

10.

McLellan E, Owen R, Stepniewska K, Sheffield J, Lemoine N . High frequency of K-ras mutations in sporadic colorectal adenomas. Gut. 1993; 34(3):392-6. PMC: 1374148. DOI: 10.1136/gut.34.3.392. View

11.

Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J . Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science. 1995; 268(5215):1336-8. DOI: 10.1126/science.7761852. View

12.

Konishi K, Yamochi T, Makino R, Kaneko K, Yamamoto T, Nozawa H . Molecular differences between sporadic serrated and conventional colorectal adenomas. Clin Cancer Res. 2004; 10(9):3082-90. DOI: 10.1158/1078-0432.ccr-03-0334. View

13.

Pan G, Ni J, Wei Y, Yu G, Gentz R, Dixit V . An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science. 1997; 277(5327):815-8. DOI: 10.1126/science.277.5327.815. View

14.

Sparks A, Morin P, Vogelstein B, Kinzler K . Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 1998; 58(6):1130-4. View

15.

Yoshimoto M, Itoh F, Yamamoto H, Hinoda Y, Imai K, YACHI A . Expression of MMP-7(PUMP-1) mRNA in human colorectal cancers. Int J Cancer. 1993; 54(4):614-8. DOI: 10.1002/ijc.2910540415. View

16.

Cunningham J, Christensen E, Tester D, Kim C, Roche P, Burgart L . Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998; 58(15):3455-60. View

17.

Behrens J, Jerchow B, Wurtele M, Grimm J, Asbrand C, Wirtz R . Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science. 1998; 280(5363):596-9. DOI: 10.1126/science.280.5363.596. View

18.

Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed J . Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science. 1997; 275(5302):967-9. DOI: 10.1126/science.275.5302.967. View

19.

De Filippo C, Luceri C, Caderni G, Pacini M, Messerini L, Biggeri A . Mutations of the APC gene in human sporadic colorectal cancers. Scand J Gastroenterol. 2002; 37(9):1048-53. DOI: 10.1080/003655202320378248. View

20.

Labbe E, Letamendia A, Attisano L . Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci U S A. 2000; 97(15):8358-63. PMC: 26952. DOI: 10.1073/pnas.150152697. View